Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 15/20 | 0.35 |
| ▸ | RXRB | P28702 | 11/20 | 0.33 |
| ▸ | RXRG | P48443 | 11/20 | 0.33 |
| ▸ | RARB | P10826 | 5/20 | 0.33 |
| ▸ | RARG | P13631 | 5/20 | 0.33 |
| ▸ | RARA | P10276 | 3/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.31 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6678059 | 0.72 | RXRA (0.49) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL11599145 | 0.71 | RXRA (0.42) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL22571560 | 0.70 | CTSD (0.32) | CTSDBACE1 | |
| SCHEMBL13732900 | 0.69 | AR (0.35) | — | |
| SCHEMBL16998437 | 0.69 | RARB (0.48) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL16998676 | 0.68 | NPC1 (0.44) | RXRARARBRARGRARA | |
| SCHEMBL18970101 | 0.68 | RARB (0.33) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL21332617 | 0.68 | CYP11B2 (0.34) | CTSDBACE1 | |
| SCHEMBL18790472 | 0.67 | RARB (0.40) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL25129965 | 0.67 | RXRA (0.45) | RXRARXRBRXRGRARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260107678-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107678-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, NR1H2, LDLR | CTSD 1959/4885BACE1 2799/4885RXRA 36/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.